Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M W Carroll

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 23, 2009
Survival and predictors of outcomes in non-HIV-infected patients with extensively drug-resistant tuberculosisD S Jeon, D H Kim, H S Kang, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 26, 1998
Recombinant modified vaccinia virus Ankara-simian immunodeficiency virus gag pol elicits cytotoxic T lymphocytes in rhesus monkeys detected by a major histocompatibility complex class I/peptide tetramerA Seth, I Ourmanov, M J Kuroda, et al.
The Journal of Experimental Medicine|July 22, 1998
gp100/pmel 17 is a murine tumor rejection antigen: induction of "self"-reactive, tumoricidal T cells using high-affinity, altered peptide ligandW W Overwijk, A Tsung, K R Irvine, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 17, 1999
Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytesW W Overwijk, D S Lee, D R Surman, et al.
Clinical and Vaccine Immunology : CVI|March 1, 2013
Evaluation of the safety and immunogenicity of a candidate tuberculosis vaccine, MVA85A, delivered by aerosol to the lungs of macaquesA D White, L Sibley, M J Dennis, et al.
Journal of Virology|June 1, 1996
Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus AnkaraV M Hirsch, T R Fuerst, G Sutter, et al.
Nature Communications|February 20, 2021
Characterisation of the T-cell response to Ebola virus glycoprotein amongst survivors of the 2013-16 West Africa epidemicT R W Tipton, Y Hall, J A Bore, et al.
Genome Announcements|February 25, 2017
First Complete Genome Sequences of Zika Virus Isolated from Febrile Patient Sera in EcuadorS Márquez, J Carrera, S T Pullan, et al.
Advances in Experimental Medicine and Biology|January 1, 1996
Host range restricted, non-replicating vaccinia virus vectors as vaccine candidatesB Moss, M W Carroll, L S Wyatt, et al.
Journal of Crohn'S & Colitis|August 11, 2021
The Phenotypic Spectrum of New-onset IBD in Canadian Children of South Asian Ethnicity: A Prospective Multi-Centre Comparative StudyJ Dhaliwal, M W Carroll, J C deBruyn, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 23, 2009
Survival and predictors of outcomes in non-HIV-infected patients with extensively drug-resistant tuberculosisD S Jeon, D H Kim, H S Kang, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 26, 1998
Recombinant modified vaccinia virus Ankara-simian immunodeficiency virus gag pol elicits cytotoxic T lymphocytes in rhesus monkeys detected by a major histocompatibility complex class I/peptide tetramerA Seth, I Ourmanov, M J Kuroda, et al.
The Journal of Experimental Medicine|July 22, 1998
gp100/pmel 17 is a murine tumor rejection antigen: induction of "self"-reactive, tumoricidal T cells using high-affinity, altered peptide ligandW W Overwijk, A Tsung, K R Irvine, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 17, 1999
Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytesW W Overwijk, D S Lee, D R Surman, et al.
Clinical and Vaccine Immunology : CVI|March 1, 2013
Evaluation of the safety and immunogenicity of a candidate tuberculosis vaccine, MVA85A, delivered by aerosol to the lungs of macaquesA D White, L Sibley, M J Dennis, et al.
Journal of Virology|June 1, 1996
Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus AnkaraV M Hirsch, T R Fuerst, G Sutter, et al.
Nature Communications|February 20, 2021
Characterisation of the T-cell response to Ebola virus glycoprotein amongst survivors of the 2013-16 West Africa epidemicT R W Tipton, Y Hall, J A Bore, et al.
Genome Announcements|February 25, 2017
First Complete Genome Sequences of Zika Virus Isolated from Febrile Patient Sera in EcuadorS Márquez, J Carrera, S T Pullan, et al.
Advances in Experimental Medicine and Biology|January 1, 1996
Host range restricted, non-replicating vaccinia virus vectors as vaccine candidatesB Moss, M W Carroll, L S Wyatt, et al.
Journal of Crohn'S & Colitis|August 11, 2021
The Phenotypic Spectrum of New-onset IBD in Canadian Children of South Asian Ethnicity: A Prospective Multi-Centre Comparative StudyJ Dhaliwal, M W Carroll, J C deBruyn, et al.
Pageof 4